
p Rxcision is the first-ever infectious disease artificial intelligence platform, designed to optimize antibiotic therapy through continuous electronic medical record monitoring and integration of clinical and microbiological data. It provides clinicians with real-time decision support for antibiotic selection, ensuring the right drug is prescribed at the right dose and time. With a library of over 80 antibiotics and a focus on antibiotic stewardship, p Rxcision aims to address the growing issue of antibiotic resistance and improve patient outcomes in infectious disease management. Founded by experts in pharmacology and drug development, the platform is scalable and integrates seamlessly with existing healthcare systems, positioning itself as a leader in the healthcare technology space.

p Rxcision is the first-ever infectious disease artificial intelligence platform, designed to optimize antibiotic therapy through continuous electronic medical record monitoring and integration of clinical and microbiological data. It provides clinicians with real-time decision support for antibiotic selection, ensuring the right drug is prescribed at the right dose and time. With a library of over 80 antibiotics and a focus on antibiotic stewardship, p Rxcision aims to address the growing issue of antibiotic resistance and improve patient outcomes in infectious disease management. Founded by experts in pharmacology and drug development, the platform is scalable and integrates seamlessly with existing healthcare systems, positioning itself as a leader in the healthcare technology space.